Big4Bio provides news and updates about the biotechnology sector, covering drugs, devices, diagnostics, and digital innovations in major biocluster regions.

Big4Bio

Big4Bio | 1,768 followers on LinkedIn. Your daily digest of life science developments in the top bioclusters in the world. | The life sciences sector is witnessing unprecedented levels of innovation and investment, while the health care industry as a whole is in the midst of a sea change. If you aren’t a full-time analyst, how can you keep up and find the key information you need to make the right decisions for your business? That’s where we come in.

Building businesses and inspiring entrepreneurs at the intersection of technology, health, and wellness

Dave Whelan

Chief Editor/Writer at Bioneex

Marie Daghlian

Digital Marketing Specialist I Creative Content Strategist I Relationship Builder I Storyteller

Cody Contois

Scientific Researcher | Editor | Technical Writer | Ph.D. | Research Analyst | Science Journalist | Scientific Blogger | Motivational Speaker

Dr. Malvika Chawla

What is the secret sauce for the investment or success of an R&D innovation company? Some would argue it's all about clear communication, strong leadership, innovative solutions, and the right connections. Biotechgate , Big4Bio , and #CoffeeBuddies can help you connect and communicate with the right people; the rest is up to you. In preparation for #JPM2025 , enter the XY Factor Competition during Pre-JPM Partnering Week, Dec 2-6, to have a pitch interview with legendary Tony Sedgwick ! The winner and runner-up of the XY Factor will be announced on a special edition of #CoffeeBuddies . 🔗 Learn more: https://lnkd.in/gUPeuPXY #BTGDigitalPartnering #JPM25 #BioWeekSF #JPMWeek #lifescience #biotech #MedTech #DigitalHealth #healthcare #BiotechBuddies

The top regional #healthcare and #biotech news for November 18th via the Big4Bio newsletters: San Diego: Avenzo Therapeutics ' Updates; Contineum Therapeutics ' IND Cleared; Illumina Seeks to Dismiss Lawsuit https://lnkd.in/gZxfBkZV SF Bay: Executive Hires; Funding for ReCode Therapeutics ; Layoffs at Gilead Sciences https://lnkd.in/gGwWXWj5 Seattle: CTT Secures $2.4M Grant; Know Labs, Inc. FY2024 Report; Upcoming Events https://lnkd.in/g54Y3Gyp Los Angeles: Arrowhead Pharmaceuticals New Phase 3 Data; BIOCELL TECH 's Sensory Device; Future Limiters of Biotech Applications https://lnkd.in/gj45Rr_e Boston: FDA Approves Syndax Pharmaceuticals ' Leukemia Drug; Ratio Therapeutics , Novartis ' Deal; Boston Pharmaceuticals , Intellia Therapeutics, Inc. Present Data https://lnkd.in/grvcbWe3 Philadelphia: Medicus Names CMO, Completes IPO; Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Closes $5M Offering; Adaptimmune CEO on Business of Biotech https://lnkd.in/gjGq9iQZ Capital Region: New Data From AbelZeta , Altimmune, Inc. ; Anticipating Biotech Limiters; BHCR's Fiercest Women https://lnkd.in/gkqyNKT9 NYC: MindMed Appoints Exec; Neurogene Inc. Trial Update; Martin Pharmaceuticals Awarded Patent; More on Eyenovia, Inc. https://lnkd.in/gXqmZna6

The top regional #healthcare and #biotech news for November 15th via the Big4Bio newsletters: San Diego: Halozyme, Inc. Offers $2B for Evotec; MediciNova, Inc. 's Patent; Upcoming Events https://lnkd.in/g4acNaC6 SF Bay: Arc Institute 's New AI Model Evo; IND Clearance for Acepodia ; More Q3 Financial Results https://lnkd.in/gnFUNYAt Seattle: Healionics Corporation 's STARgraft Gains FDA Device Designation; BioLife Solutions, Inc. Sells Subsidiary; Bill & Melinda Gates Foundation MRI Mission https://lnkd.in/gewmM7xS Los Angeles: GordonMD® Global Investments LP 's Flare Teams With Roche ; UCLA 's Spinal Growth Discovery; Otsuka Pharmaceutical Companies (U.S.) , ICU Medical Joint Venture; Haemonetics Facility Closure https://lnkd.in/gzEBbPkF Boston: Omega Therapeutics Halts Clinical-Stage Program; HARBOUR BIOMED Names Exec; More on bluebird bio , Sensei Bio https://lnkd.in/gfXP-a97 Philadelphia: Gilead Sciences Closing Local Office; Endo , Paladin Pharma 's Deal; More on Adaptimmune https://lnkd.in/gA5dC5r7 Capital Region: Sensei Bio Shutters Rockville Site; Aurinia Pharmaceuticals Inc. Unveils Data; New Milken Institute Funding, Collaborations; Quarterly Results https://lnkd.in/gss7baK6 NYC: Merck Buys Bispecific for $588M; Regeneron Drug Reconsidered; Sparian Biosciences Awarded NIH Grant; More on PTC Therapeutics, Inc.

Don't miss the opportunity to gain insights and more at one of the last partnering events of the year! Find new partners and investors at this great Biotechgate Digital Partnering event AND prepare for #JPM2025 — some of the great online sessions include: ➡️ Dec 3rd - Partnering Tutorial for RESI JPM Join Life Science Nation staff as they walk you through their system and how it can help you identify partners who are the best fit for you, how to manage your outreach, their recommended strategy for follow-up, and how to take advantage of the content that they provide to ensure your best possible RESI JPM experience. ➡️ Dec 4th - Demy-Colton Virtual Salon: 2025 TechBio Investor and Technology Trends at Biotech Showcase During Healthcare Week Join Demy-Colton for an insightful webinar featuring a panel of TechBio CEOs, venture investors, and industry experts as they discuss the latest trends and innovations shaping the future of human health during Biotech Showcase and Healthcare Week, January 13th-15th in San Francisco. ➡️ Dec 5th - The Art of Fundraising Join this special session from Danforth Advisors , as they provide the life sciences community with corporate and clinical outsourcing support at all stages of a company's fundraising lifecycle. Co-hosted by Life Sciences Pennsylvania . And don’t forget #CoffeeBuddies sessions throughout the week as well as the XY Factor pitch competition! 🔗 Learn more and register: https://lnkd.in/ee8xEWC #BTGDigitalPartnering #JPM25 #BioWeekSF #JPMWeek #lifescience #biotech #MedTech #DigitalHealth #healthcare #BiotechBuddies

The top regional #healthcare and #biotech news for November 14th via the Big4Bio newsletters: San Diego: Neurelis, Inc. Enters $208M Deal; GIOSTAR 's IND Cleared; Calidi Biotherapeutics Prices $7.5M Offering https://lnkd.in/gaj-5SwN SF Bay: Allogene Therapeutics Abandons Leukemia Plans; ALX Oncology Names CMO; Q3 Financial Results https://lnkd.in/gnVCKSv5 Seattle: University of Washington Receives $13.6M; Turner Joins Avalyn Pharma ; Gilead Sciences to Close Seattle Office https://lnkd.in/grN5yPQE Los Angeles: Beta Bionics Secures $60M; TAE Life Sciences & Stella Pharma Strategic Collab; Hot Investor Profiles https://lnkd.in/g67MKTyy Boston: Exec Changes; Pulmatrix Inc. , Cullgen Inc. 's Merger; Abpro 's SPAC Deal Closes; Layoffs at Orna Therapeutics https://lnkd.in/gzp-tSTh Philadelphia: Adaptimmune Aces Trial; Exec Change at Windtree Therapeutics, Inc. ; More on Marinus Pharma Layoffs https://lnkd.in/gdSr-HHn Capital Region: Longhorn Vaccines and Diagnostics, LLC Combats Sepsis; MaxCyte, Inc. celebrates 25 years; Shuttle Pharmaceuticals, Inc. 3Q update. https://lnkd.in/gzC9vXUj NYC: Johnson & Johnson MedTech Gains IDE Approval; Tharimmune, Inc. European Patent Granted; Third Quarter Financial Results https://lnkd.in/gU6y2Ae5

🎙️ Have you listened to our latest podcast episode? We dive into the newly released ICH M12 guidelines, which set a global standard for drug-drug interaction studies. Hear insights from Charles River Laboratories ' Michael V Templin , Senior Principal Scientific Advisor, and Marko Andric , Senior Business Development Director, as they discuss the key changes, how drug developers can adapt in pre-clinical development, and the tools to help ensure compliance. 🎙️ Listen here: https://lnkd.in/gZyhHYma #lifescience #healthcare #biotech #drugdevelopment #pharma

The top regional #healthcare and #biotech news for November 13th via the Big4Bio newsletters: San Diego: Cullgen Inc. , Pulmatrix Inc. 's Merger; Daré Bioscience, Inc. Awarded Grant; First Cell Membranes https://lnkd.in/grNt7n7q SF Bay: TRexBio 's $84M Series B; GenEdit Names CSO; Secrets of Ketosis https://lnkd.in/gMdg2RKJ Seattle: Seattle Q3 2024 Life Sciences Market Report; Fred Hutch Patient Care Tackles Infant RSV; Natural Supplement Revives Aging Heart https://lnkd.in/gR2DZETC Los Angeles: Amgen Loses $12B on Hidden Obesity Data; Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) 's ZORYVE Named Top Eczema Treatment; Tarsus Pharmaceuticals, Inc. Expands Board https://lnkd.in/gA6-seR7 Boston: Exec Hires; Syros Pharmaceuticals ' Blood Cancer Drug Fails; Q3 Financial Data; More on Syndax Pharmaceuticals https://lnkd.in/gegynrHF Philadelphia: Vittoria Biotherapeutics, Inc. Completes $25M Financing; AstraZeneca to Create 1,000+ New Jobs; More Q3 Results https://lnkd.in/ghEtmQkS Capital Region: CorVista® Health Partners with ATSS; Third Quarter Financial Results; National Cancer Institute (NCI) reveals new insights https://lnkd.in/gS8rsjVX NYC: Merck 's Phase 3 Trial; Intercept Pharmaceuticals Receives FDA Response; Third Quarter Financial Results https://lnkd.in/gfvqDKfY

We're excited to be at the 7th Annual Symposium for Life Science Real Estate Development! This event is an incredible opportunity to connect with the #lifesciences and real estate communities, diving into the latest trends, challenges, and developments shaping the Greater New York Metro area. Thank you Builds Bio+ for hosting such a great event and bringing together the life sciences and real estate communities. #biotech #healthcare #realestate #newyork

The top regional #healthcare and #biotech news for November 12th via the Big4Bio newsletters: San Diego: ARS Pharmaceuticals, Inc. 's Exclusive Deal; Wugen Names CMO; Key ALS Pathway Identified https://lnkd.in/gur2brqB SF Bay: Exec Hires; Trace Neuroscience Launches; RAPT Therapeutics Drops Program; Layoffs at 23andMe https://lnkd.in/gvGucxRH Seattle: BioLife Solutions, Inc. Sells SciSafe for $73M; Aptevo Therapeutics Inc & Alligator Bioscience AB Bispecific Success; SystImmune IND Cleared for Advanced Solid Tumors https://lnkd.in/gNpwfB7u Los Angeles: Theragent Inc & Cellvax 's Phase 2 Immunotherapy; Amgen a Best Place to Work in Biopharma; Role of BMI in Disease Risk https://lnkd.in/gAF9zuqR Boston: Attivare Therapeutics Names CEO; Flare Therapeutics , Vesalius Therapeutics Strike Major Deals; Layoffs at Thermo Fisher Scientific https://lnkd.in/g3UCUnGu Philadelphia: Medicus Pharma Ltd. Readies for IPO; Kanvas Biosciences Unveils Data; Strata Skin Sciences Court Order https://lnkd.in/gqxxf2SM Capital Region: Clinical Hold on Novavax Lifted; Altimmune, Inc. Names CFO; Upcoming Events https://lnkd.in/gkyPJFNf NYC: Neurogene Inc. Stock Tanks; Schrödinger , Novartis ' Deal; TEVOGEN BIO Enhancing R&D Facilities https://lnkd.in/gPP5KCmx

Important #podcast from Big4Bio: How Will New Regulatory Harmonization Impact Drug Developers? https://lnkd.in/g_Z9eJae The recently released update to the International Council for Harmonisation M12 guidelines provides a consistent approach to drug-drug interaction studies across different regulatory agencies. The new guidelines replace regional and local ones and set a global standard for addressing drug-drug interactions. We spoke to Michael Templin, Senior Principal Scientific Advisor for Charles River Laboratories ; and Marko Andric, Senior Business Development Director, Late Discovery, for Charles River; about the new guidelines, changes drug developers will need to make in their approach to pre-clinical development, and the tools and technologies that might help them comply. A related webinar on the guidelines can be found at https://lnkd.in/giJGeft5

BIG4

COM:BIG4BIO

Big4Bio